| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-07 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-06 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.57 | 3e-05 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |